Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations
- PMID: 37510549
- PMCID: PMC10379370
- DOI: 10.3390/healthcare11142109
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations
Abstract
Underserved populations have a wide heterogeneity on healthcare provision and use. They also represent the key populations according to WHO 2030 goals for HCV micro-elimination. Our review evaluated the available literature on HCV diagnosis, staging, and treatment among underserved populations, such as incarcerated people, patients with psychiatric disorders, and migrants. A narrative review of literature was performed using key electronic databases (Scopus, Pubmed-MEDLINE) and search engines (Google Scholar). Peer-reviewed publications, grey literature on HCV, and recent models proposed for micro-elimination in underserved populations were included. An insight into the COVID-19 pandemic and its influence on HCV micro-elimination pathways will be also provided. Regarding prison settings, a progressive reduction in HCV epidemiology among incarcerated people in the last years was found (one-third of the level it had been before). People suffering from psychiatric disorders have a high anti-HCV prevalence, but there is a lack of data on active infections. A bidirectional relationship between HCV and psychiatric disorders was found. Migrants showed a very inconsistent assessment of HCV. Furthermore, available studies recorded data from populations with high heterogeneity of anti-HCV prevalence, Therefore, the reported results need caution in their evaluation.
Keywords: HCV; asylum seekers; incarcerated people; migrants; psychiatric disorders; refugees; underserved populations; undocumented migrants.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Chronic Viral Hepatitis in the Italian Prison Setting: Prevalence, Outcomes, Literature Needs and Perspectives.Healthcare (Basel). 2021 Sep 9;9(9):1186. doi: 10.3390/healthcare9091186. Healthcare (Basel). 2021. PMID: 34574960 Free PMC article. Review.
-
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects.BMC Infect Dis. 2022 Jul 7;22(1):601. doi: 10.1186/s12879-022-07565-2. BMC Infect Dis. 2022. PMID: 35799126 Free PMC article.
-
"We want our freedom back, that's our only need": a qualitative study of health and social needs among asylum seekers and undocumented migrants crossing the borders from Belarus to Lithuania.Front Public Health. 2024 May 2;12:1371119. doi: 10.3389/fpubh.2024.1371119. eCollection 2024. Front Public Health. 2024. PMID: 38756883 Free PMC article.
-
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy.Infect Dis Poverty. 2024 May 28;13(1):39. doi: 10.1186/s40249-024-01200-9. Infect Dis Poverty. 2024. PMID: 38802954 Free PMC article.
-
Health records for migrants and refugees: A systematic review.Health Policy. 2019 Sep;123(9):888-900. doi: 10.1016/j.healthpol.2019.07.018. Epub 2019 Jul 30. Health Policy. 2019. PMID: 31439455
Cited by
-
The Key Importance of Screening Underprivileged People in Order to Achieve Global Hepatitis Virus Elimination Targets.Viruses. 2025 Feb 14;17(2):265. doi: 10.3390/v17020265. Viruses. 2025. PMID: 40007020 Free PMC article. Review.
References
-
- Fiore V., Ranieri R., Dell’Isola S., Pontali E., Barbarini G., Prestileo T., Marri D., Starnini G., Sotgiu G., Madeddu G., et al. Feasibility and efficacy of 8 week Glecaprevir/Pibrentasvir to treat incarcerated viraemic HCV patients: A case-control study. Liver Int. 2021;41:271–275. doi: 10.1111/liv.14745. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources